Infliximab for medical induction of remission in Crohn's disease.

Gordon M, Sinopoulou V, Akobeng AK, Radford SJ, Eldragini MEAA, Darie AM, Moran GW

Open source

DOI
10.1002/14651858.cd012623.pub2
Published
2023 Nov 20
Container
The Cochrane database of systematic reviews
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/14651858.cd012623.pub2,
  title = {Infliximab for medical induction of remission in Crohn's disease.},
  author = {Gordon M and Sinopoulou V and Akobeng AK and Radford SJ and Eldragini MEAA and Darie AM and Moran GW},
  year = {2023},
  journal = {The Cochrane database of systematic reviews},
  doi = {10.1002/14651858.cd012623.pub2},
  url = {https://doi.org/10.1002/14651858.cd012623.pub2}
}

RIS

TY  - JOUR
TI  - Infliximab for medical induction of remission in Crohn's disease.
AU  - Gordon M
AU  - Sinopoulou V
AU  - Akobeng AK
AU  - Radford SJ
AU  - Eldragini MEAA
AU  - Darie AM
AU  - Moran GW
PY  - 2023
JO  - The Cochrane database of systematic reviews
DO  - 10.1002/14651858.cd012623.pub2
UR  - https://doi.org/10.1002/14651858.cd012623.pub2
ER  - 

APA

M, G., V, S., AK, A., SJ, R., MEAA, E., AM, D., & GW, M. (2023). Infliximab for medical induction of remission in Crohn's disease.. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd012623.pub2

Source records